129 related articles for article (PubMed ID: 28677734)
1. Overexpression of SET oncoprotein is associated with tumor progression and poor prognosis in human gastric cancer.
Yuan X; Zhang T; Zheng X; Zhang Y; Feng T; Liu P; Sun Z; Qin S; Liu X; Zhang L; Song J; Liu Y
Oncol Rep; 2017 Sep; 38(3):1733-1741. PubMed ID: 28677734
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of PP2A inhibitor SET oncoprotein is associated with tumor progression and poor prognosis in human non-small cell lung cancer.
Liu H; Gu Y; Wang H; Yin J; Zheng G; Zhang Z; Lu M; Wang C; He Z
Oncotarget; 2015 Jun; 6(17):14913-25. PubMed ID: 25945834
[TBL] [Abstract][Full Text] [Related]
3. H19 serves as a diagnostic biomarker and up-regulation of H19 expression contributes to poor prognosis in patients with gastric cancer.
Chen JS; Wang YF; Zhang XQ; Lv JM; Li Y; Liu XX; Xu TP
Neoplasma; 2016; 63(2):223-30. PubMed ID: 26774144
[TBL] [Abstract][Full Text] [Related]
4. CXCR6 predicts poor prognosis in gastric cancer and promotes tumor metastasis through epithelial-mesenchymal transition.
Jin JJ; Dai FX; Long ZW; Cai H; Liu XW; Zhou Y; Hong Q; Dong QZ; Wang YN; Huang H
Oncol Rep; 2017 Jun; 37(6):3279-3286. PubMed ID: 28440473
[TBL] [Abstract][Full Text] [Related]
5. Upregulation of miRNA‑301a‑3p promotes tumor progression in gastric cancer by suppressing NKRF and activating NF‑κB signaling.
Xu X; Xia Y; Ma J; Li W; Niu N; Li X; Tao H; Xu J; He X
Int J Oncol; 2020 Aug; 57(2):522-532. PubMed ID: 32468020
[TBL] [Abstract][Full Text] [Related]
6. Upregulated expression of long noncoding RNA SNHG15 promotes cell proliferation and invasion through regulates MMP2/MMP9 in patients with GC.
Chen SX; Yin JF; Lin BC; Su HF; Zheng Z; Xie CY; Fei ZH
Tumour Biol; 2016 May; 37(5):6801-12. PubMed ID: 26662309
[TBL] [Abstract][Full Text] [Related]
7. Antisense Long Noncoding RNA HIF1A-AS2 Is Upregulated in Gastric Cancer and Associated with Poor Prognosis.
Chen WM; Huang MD; Kong R; Xu TP; Zhang EB; Xia R; Sun M; De W; Shu YQ
Dig Dis Sci; 2015 Jun; 60(6):1655-62. PubMed ID: 25686741
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of miR-892a in gastric cancer and its regulatory effect on tumor progression.
Lv J; Zhang H; Gao Z; Zhang X; Huang X; Jia X
Cancer Biomark; 2020; 28(2):247-254. PubMed ID: 32390603
[TBL] [Abstract][Full Text] [Related]
9. Reduced Kiss‑1 expression is associated with clinical aggressive feature of gastric cancer patients and promotes migration and invasion in gastric cancer cells.
Li C; Yuan L; Han S; Xuan M; Liu D; Tian B; Yu W
Oncol Rep; 2020 Sep; 44(3):1149-1157. PubMed ID: 32705229
[TBL] [Abstract][Full Text] [Related]
10. NDRG1 Controls Gastric Cancer Migration and Invasion through Regulating MMP-9.
Chang X; Xu X; Xue X; Ma J; Li Z; Deng P; Chen J; Zhang S; Zhi Y; Dai D
Pathol Oncol Res; 2016 Oct; 22(4):789-96. PubMed ID: 27154576
[TBL] [Abstract][Full Text] [Related]
11. Increased Expression of 58-kDa Microspherule Protein (MSP58) in Human Gastric Cancer Promotes Cell Proliferation and Correlates with Poor Patient Survival.
Cui J; Xi H; Cai A; Ma L; Bian S; Zhang K; Wei B; Chen L
Clin Lab; 2016; 62(6):993-1001. PubMed ID: 27468560
[TBL] [Abstract][Full Text] [Related]
12. KIF14 promotes tumor progression and metastasis and is an independent predictor of poor prognosis in human gastric cancer.
Yang Z; Li C; Yan C; Li J; Yan M; Liu B; Zhu Z; Wu Y; Gu Q
Biochim Biophys Acta Mol Basis Dis; 2019 Jan; 1865(1):181-192. PubMed ID: 30404039
[TBL] [Abstract][Full Text] [Related]
13. The effect and clinical significance of FN1 expression on biological functions of gastric cancer cells.
Zhou Y; Cao G; Cai H; Huang H; Zhu X
Cell Mol Biol (Noisy-le-grand); 2020 Jul; 66(5):191-198. PubMed ID: 33040835
[TBL] [Abstract][Full Text] [Related]
14. Up-regulation of long non-coding RNA PCAT-1 correlates with tumor progression and poor prognosis in gastric cancer.
Cui WC; Wu YF; Qu HM
Eur Rev Med Pharmacol Sci; 2017 Jul; 21(13):3021-3027. PubMed ID: 28742205
[TBL] [Abstract][Full Text] [Related]
15. Elevated Orai1 and STIM1 expressions upregulate MACC1 expression to promote tumor cell proliferation, metabolism, migration, and invasion in human gastric cancer.
Xia J; Wang H; Huang H; Sun L; Dong S; Huang N; Shi M; Bin J; Liao Y; Liao W
Cancer Lett; 2016 Oct; 381(1):31-40. PubMed ID: 27431311
[TBL] [Abstract][Full Text] [Related]
16. FTO expression is associated with the occurrence of gastric cancer and prognosis.
Xu D; Shao W; Jiang Y; Wang X; Liu Y; Liu X
Oncol Rep; 2017 Oct; 38(4):2285-2292. PubMed ID: 28849183
[TBL] [Abstract][Full Text] [Related]
17. miR-335 directly, while miR-34a indirectly modulate survivin expression and regulate growth, apoptosis, and invasion of gastric cancer cells.
Yang B; Huang J; Liu H; Guo W; Li G
Tumour Biol; 2016 Feb; 37(2):1771-9. PubMed ID: 26318298
[TBL] [Abstract][Full Text] [Related]
18. ING5 suppresses proliferation, apoptosis, migration and invasion, and induces autophagy and differentiation of gastric cancer cells: a good marker for carcinogenesis and subsequent progression.
Gou WF; Shen DF; Yang XF; Zhao S; Liu YP; Sun HZ; Su RJ; Luo JS; Zheng HC
Oncotarget; 2015 Aug; 6(23):19552-79. PubMed ID: 25980581
[TBL] [Abstract][Full Text] [Related]
19. miR-215 promotes malignant progression of gastric cancer by targeting RUNX1.
Li N; Zhang QY; Zou JL; Li ZW; Tian TT; Dong B; Liu XJ; Ge S; Zhu Y; Gao J; Shen L
Oncotarget; 2016 Jan; 7(4):4817-28. PubMed ID: 26716895
[TBL] [Abstract][Full Text] [Related]
20. miR-130a acts as a potential diagnostic biomarker and promotes gastric cancer migration, invasion and proliferation by targeting RUNX3.
Jiang H; Yu WW; Wang LL; Peng Y
Oncol Rep; 2015 Sep; 34(3):1153-61. PubMed ID: 26134263
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
